temporal

The paper 'GUIDE Communication Framework: Developing Skills to Improve Nurse-Patient Interactions' was published in the Clinical Journal of Oncology Nursing in December 2021. Read the paper and download the slides to find out more about GUIDE.


GUIDE helps nurses to empower patients through guidance and support. The five letters in GUIDE stand for
Gaining insight into the goals of treatment and care
Understanding the gaps in the patient's knowledge
Informing and educating
Directing to additional support
Empowering patients

Sven De Keersmaecker works as a Study Coordinator at the Antwerp University Hospital since 2015, caring for study patients and outpatients. Sven is a graduate nurse since 1997 and worked initially in Intensive Care before moving to work in Oncology in Antwerp in 2000. Over the years, he acted as a nurse navigator in digestive oncology and was involved in the development of coaching programs for patient and health informatics tools to help them with compliance and monitoring of side effects.

Fransen McGinley is a certified physicians assistant in the Gastrointestinal Cancers Clinic at the Stephenson Cancer Center, Oklahoma City. After completing her bachelor’s degree in Microbiology at the University of Oklahoma, she earned her master’s degree from the University of Oklahoma Health Sciences Physician Associate Program. Fransen has more than 12 years of experience as an oncology PA at the University of Oklahoma Health Sciences Center. She is an active member of the National Commission on Certification of Physician Assistants, as well as of the Oklahoma Academy of Physician Assistants.

Nina Grenon is a nurse practitioner caring for patients with Gastrointestinal Cancers for the past 22 years, 14 at the Dana-Farber Cancer Institute and the previous 8 years at the Massachusetts General Hospital Cancer Center. She is adjunct faculty at Simmons College, School of Nursing and Health Sciences and serves as a clinical preceptor for nurse practitioner students at Yale University, Simmons College and MGH Institute of Health Professions. She serves on the North America Neuroendocrine Association Tumor Society, regional education committee. Nina Grenon is a frequent national and regional lecturer in colon and pancreatic cancer, published a number of articles in the nursing implication in the management of side effects in patients treated for colon cancer. She is currently on the Oncology Nursing Society Congress Planning Team for 2020. Her research and quality improvement interest include patient and care taker education, specific intervention delivered by front line nurses and the early integrating of palliative care in patients with advanced gastrointestinal malignancies specifically pancreatic cancer.

The GUIDE Communication Framework: shared decision-making tool

Episode

2

of

episodes
GI NURSES CONNECT
Experts
Fransen McGinley, Nina Grenon, Sven De Keersmaecker
Endorsed By
Fight Colorectal Cancer Digestive Cancers Europe
  • download Downloadable
    Resouces
  • clock 60 MIN
  • calendar Sep 2021
  • EACCME
This educational programme is supported by an Independent Medical Education Grant from Bayer
Programme summary
  • clock Duration 20 MIN
  • clock Language(s) flag
Read the publication now
Share this programme
This educational programme is supported by an Independent Medical Education Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI NURSES CONNECT

GI NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Medical Grants from Bayer and Eisai Europe Limited.

Meet the experts

Other programmes of interest

podcast Podcast
Oncology 
Perseverance in molecular testing in NSCLC pays off

Looking beyond the obvious mutations in non-small-cell lung cancer

Experts
Prof. Frédérique Penault-Llorca, Prof. Mark Socinski
  • download Downloadable
    Resources
  • clock 26 MIN
  • calendar Mar 2024

Educational programme supported by an Independent Medical Education grant from Bayer
conference-update Conference update
Oncology 
ER+ advanced breast cancer: Highlights from EBCC-14 satellite symposium

Medical experts discuss current and upcoming treatment strategies to use after CDK4/6 inhibitors in patients with ER+/HER2- advanced breast cancer

Experts
Prof. Valentina Guarneri, Prof. Matteo Lambertini, Prof. Federico Rojo
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Mar 2024

Educational programme supported by an Independent Medical Education grant from Menarini Stemline.
interactive-patient-case Interactive patient case
Oncology 
TRK fusion-positive lung cancer: Diagnosis and treatment

Make decisions for your patient at two key stages in their journey

Experts
Prof. Fernando López-Ríos, Prof. Mark Socinski
  • clock 60 MIN
  • calendar Mar 2024

Educational programme supported by an Independent Medical Education grant from Bayer
conference-update Conference update
Oncology 
ESMO 2023: Lung cancer update

Experts discuss new lung cancer data at a meeting hosted by eChinaHealth and COR2ED

  • clock 43 MIN
  • calendar Mar 2024

Educational programme supported by an Independent Medical Education grant from This educational programme is supported by an Independent Medical Education Grant from SystImmune and BeiGene Europe.
other Other
Oncology 
Lung cancer survey: Patient views on biomarker testing

Share the survey with patients with lung cancer and their caregivers

Experts
Prof. Christian Rolfo, Prof. Fernando López-Ríos
Endorsed by
LUNGevity
Lung Cancer Europe IASLC
The Israeli Lung Cancer Foundation ISLB
  • download Downloadable
    Resources
  • clock 2 MIN
  • calendar Mar 2024

Educational programme supported by an Independent Medical Education grant from Bayer.
podcast Podcast
Oncology 
Precision oncology approaches in lung cancer

Explore pre-analytical phase challenges and biomarker testing in lung cancer. Moderated by the Oncology Brothers.

Experts
Dr Bruna Pellini, Dr Semir Vranić, Oncology Brothers (Moderators)
Endorsed by
AMP
  • download Downloadable
    Resources
  • clock 25 MIN
  • calendar Mar 2024

Educational programme supported by an Independent Medical Education grant from AstraZeneca and Amoy Diagnostics.